Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for YBX1_FOS_NFYC_NFYA_NFYB_CEBPZ
Z-value: 4.06
Motif logo
Transcription factors associated with YBX1_FOS_NFYC_NFYA_NFYB_CEBPZ
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
YBX1
|
ENSG00000065978.13 | Y-box binding protein 1 |
|
FOS
|
ENSG00000170345.5 | Fos proto-oncogene, AP-1 transcription factor subunit |
|
NFYC
|
ENSG00000066136.15 | nuclear transcription factor Y subunit gamma |
|
NFYA
|
ENSG00000001167.10 | nuclear transcription factor Y subunit alpha |
|
NFYB
|
ENSG00000120837.3 | nuclear transcription factor Y subunit beta |
|
CEBPZ
|
ENSG00000115816.9 | CCAAT enhancer binding protein zeta |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| FOS | hg19_v2_chr14_+_75745477_75745680 | 0.64 | 1.5e-04 | Click! |
| NFYA | hg19_v2_chr6_+_41040678_41040722 | 0.44 | 1.5e-02 | Click! |
| YBX1 | hg19_v2_chr1_+_43148059_43148111 | 0.33 | 7.9e-02 | Click! |
| NFYC | hg19_v2_chr1_+_41157671_41157695 | -0.25 | 1.8e-01 | Click! |
| NFYB | hg19_v2_chr12_-_104531945_104531996 | 0.17 | 3.8e-01 | Click! |
| CEBPZ | hg19_v2_chr2_-_37458749_37458856 | -0.16 | 4.1e-01 | Click! |
Activity profile of YBX1_FOS_NFYC_NFYA_NFYB_CEBPZ motif
Sorted Z-values of YBX1_FOS_NFYC_NFYA_NFYB_CEBPZ motif
Network of associatons between targets according to the STRING database.
First level regulatory network of YBX1_FOS_NFYC_NFYA_NFYB_CEBPZ
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.3 | 22.0 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 7.1 | 21.3 | GO:2000775 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 5.9 | 17.8 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 5.4 | 16.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 4.9 | 24.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 4.5 | 22.5 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 4.5 | 40.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 4.1 | 12.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 3.6 | 17.9 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 3.1 | 18.7 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 3.1 | 12.2 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 2.9 | 8.7 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 2.9 | 8.7 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 2.8 | 11.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 2.8 | 13.8 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 2.7 | 2.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 2.5 | 7.6 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 2.5 | 7.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 2.5 | 7.4 | GO:0071373 | cellular response to cocaine(GO:0071314) cellular response to luteinizing hormone stimulus(GO:0071373) |
| 2.4 | 2.4 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 2.3 | 9.3 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 2.3 | 6.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 2.2 | 6.7 | GO:0072034 | renal vesicle induction(GO:0072034) |
| 2.1 | 12.7 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 2.1 | 21.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 2.0 | 8.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 2.0 | 6.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.9 | 17.5 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 1.9 | 15.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 1.9 | 1.9 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 1.9 | 7.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 1.9 | 11.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 1.8 | 5.5 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 1.8 | 26.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 1.8 | 8.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.8 | 5.3 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 1.7 | 8.7 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
| 1.6 | 11.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 1.5 | 6.2 | GO:0006272 | leading strand elongation(GO:0006272) |
| 1.5 | 4.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 1.5 | 7.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.4 | 52.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 1.4 | 15.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 1.4 | 2.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.4 | 31.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 1.3 | 1.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 1.3 | 6.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 1.3 | 6.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.2 | 6.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 1.2 | 3.6 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.2 | 3.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 1.2 | 4.8 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 1.2 | 3.5 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 1.2 | 11.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 1.2 | 4.7 | GO:1904647 | response to rotenone(GO:1904647) |
| 1.2 | 3.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 1.1 | 9.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 1.1 | 3.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 1.1 | 14.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 1.0 | 130.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 1.0 | 5.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.9 | 2.8 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.9 | 3.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.9 | 3.7 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.9 | 21.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.9 | 4.5 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.9 | 21.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.9 | 4.5 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.9 | 5.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.9 | 11.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.9 | 4.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.9 | 9.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.9 | 18.1 | GO:0043486 | histone exchange(GO:0043486) |
| 0.8 | 5.9 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.8 | 10.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.8 | 17.6 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.8 | 2.4 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.8 | 2.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.8 | 31.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.8 | 2.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.7 | 2.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.7 | 0.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.7 | 2.2 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.7 | 7.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.7 | 3.6 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.7 | 4.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.7 | 2.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.7 | 2.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.7 | 2.0 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.7 | 0.7 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.7 | 1.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.7 | 35.5 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.6 | 2.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.6 | 2.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.6 | 3.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.6 | 1.9 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.6 | 1.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.6 | 3.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.6 | 2.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.6 | 0.6 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.6 | 3.7 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.6 | 2.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.6 | 1.8 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.6 | 2.4 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.6 | 17.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
| 0.6 | 3.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.6 | 1.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.6 | 16.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.6 | 1.7 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.6 | 2.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.6 | 1.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.6 | 2.3 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.6 | 1.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.6 | 6.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.6 | 3.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.6 | 1.7 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.6 | 2.2 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.6 | 2.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.6 | 1.7 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.5 | 3.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.5 | 1.6 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
| 0.5 | 3.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.5 | 8.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.5 | 10.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
| 0.5 | 19.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.5 | 2.6 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.5 | 2.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.5 | 4.6 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.5 | 2.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.5 | 2.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.5 | 3.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 | 2.0 | GO:0010481 | ectoderm and mesoderm interaction(GO:0007499) epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.5 | 1.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.5 | 1.9 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) xanthine metabolic process(GO:0046110) |
| 0.5 | 2.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.5 | 0.5 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 0.5 | 1.4 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.5 | 1.8 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.5 | 5.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.4 | 1.3 | GO:0032773 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.4 | 0.4 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 0.4 | 1.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.4 | 5.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.4 | 5.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
| 0.4 | 0.4 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.4 | 1.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.4 | 1.3 | GO:2000412 | activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 0.4 | 1.3 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.4 | 23.7 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.4 | 0.8 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
| 0.4 | 3.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.4 | 2.0 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.4 | 41.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.4 | 2.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.4 | 3.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.4 | 5.1 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
| 0.4 | 2.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 | 23.4 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.4 | 0.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
| 0.4 | 2.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 2.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.4 | 1.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.4 | 1.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.4 | 17.7 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.4 | 3.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.4 | 5.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.4 | 2.6 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.4 | 3.0 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.4 | 6.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.4 | 0.4 | GO:0010628 | positive regulation of gene expression(GO:0010628) |
| 0.4 | 3.7 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.4 | 2.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.4 | 12.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.4 | 1.4 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 0.4 | 1.4 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.3 | 1.7 | GO:0030047 | actin modification(GO:0030047) |
| 0.3 | 1.7 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.3 | 1.0 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.3 | 2.4 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.3 | 3.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.3 | 0.3 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.3 | 4.7 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.3 | 10.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 | 0.3 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.3 | 1.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.3 | 0.9 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.3 | 0.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 | 0.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 | 5.5 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.3 | 1.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.3 | 1.7 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.3 | 2.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.3 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.3 | 0.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.3 | 0.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.3 | 0.3 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.3 | 1.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.3 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.3 | 6.7 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.3 | 0.8 | GO:0030860 | neuroblast division in subventricular zone(GO:0021849) regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 | 1.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.3 | 2.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 | 4.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 0.5 | GO:0009188 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.3 | 1.0 | GO:0090399 | replicative senescence(GO:0090399) |
| 0.3 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.3 | 4.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 | 0.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.3 | 2.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.3 | 10.8 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.3 | 1.5 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 1.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.2 | 1.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 | 0.7 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.2 | 1.5 | GO:0046985 | negative regulation of megakaryocyte differentiation(GO:0045653) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.2 | 1.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.2 | 0.7 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.2 | 1.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.2 | 1.9 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 1.0 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.2 | 1.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.2 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.2 | 1.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.2 | 14.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.2 | 0.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.2 | 0.2 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.2 | 3.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 1.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.2 | 0.5 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
| 0.2 | 1.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.2 | 2.7 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.2 | 0.5 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.2 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.2 | 0.7 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 0.2 | 2.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
| 0.2 | 2.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 | 0.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.2 | 2.8 | GO:0042407 | cristae formation(GO:0042407) |
| 0.2 | 3.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.2 | 0.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.2 | 0.6 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.2 | 1.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 0.8 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 0.2 | 1.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 2.5 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.2 | 0.8 | GO:1902164 | platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 | 1.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 | 0.6 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 | 1.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.2 | 0.8 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.2 | 0.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.2 | 0.2 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.2 | 1.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 1.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 | 0.4 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.2 | 1.0 | GO:1990834 | response to odorant(GO:1990834) |
| 0.2 | 1.6 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.2 | 0.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 2.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.2 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.2 | 2.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 | 1.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.2 | 1.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 | 0.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 0.6 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.2 | 3.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.2 | 0.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.2 | 1.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 | 0.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 2.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 1.4 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.2 | 0.5 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.2 | 0.2 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 | 0.7 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.2 | 0.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.2 | 3.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.2 | 7.0 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.2 | 0.7 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.2 | 0.8 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.2 | 3.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 | 1.0 | GO:0072602 | interleukin-33-mediated signaling pathway(GO:0038172) interleukin-4 secretion(GO:0072602) |
| 0.2 | 1.3 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 | 4.5 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
| 0.2 | 0.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.2 | 3.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 1.5 | GO:0046618 | drug export(GO:0046618) |
| 0.2 | 0.5 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
| 0.2 | 2.1 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
| 0.2 | 3.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.2 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 | 0.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.2 | 0.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 0.2 | 11.7 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.2 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 | 4.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.2 | 2.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.7 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.1 | 1.6 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 0.1 | 2.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 2.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 | 1.5 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 0.8 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 0.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.1 | 1.9 | GO:0000050 | urea cycle(GO:0000050) |
| 0.1 | 0.8 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
| 0.1 | 0.7 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.1 | 2.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.1 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 | 0.5 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.1 | GO:0042113 | B cell activation(GO:0042113) |
| 0.1 | 1.3 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.1 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 0.5 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 | 6.1 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 3.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 0.4 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 | 3.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 0.7 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 0.1 | 0.4 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.1 | 0.4 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.1 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 3.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 | 1.0 | GO:0030578 | PML body organization(GO:0030578) |
| 0.1 | 0.1 | GO:0042640 | anagen(GO:0042640) |
| 0.1 | 0.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 | 0.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 0.6 | GO:0019303 | D-ribose metabolic process(GO:0006014) D-ribose catabolic process(GO:0019303) |
| 0.1 | 0.8 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.1 | 0.5 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.1 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 0.7 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.1 | 0.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.1 | 0.3 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.1 | 0.4 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.1 | 0.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 3.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 | 0.4 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
| 0.1 | 0.4 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 1.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 0.4 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.1 | 0.3 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 0.8 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.1 | 0.7 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.3 | GO:0045659 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.1 | 0.3 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.1 | 0.6 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 | 1.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.6 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.1 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.3 | GO:0014062 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.1 | 0.3 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.1 | 0.3 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 | 0.2 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.1 | 1.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 | 0.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.1 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 | 1.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 1.4 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.1 | 0.7 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 0.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.1 | 0.2 | GO:0003160 | endocardium morphogenesis(GO:0003160) cardiac endothelial cell differentiation(GO:0003348) endocardium formation(GO:0060214) endocardial cell differentiation(GO:0060956) |
| 0.1 | 0.6 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.1 | 5.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.1 | 0.3 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.1 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.1 | 0.5 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 | 0.4 | GO:2000275 | cellular amide catabolic process(GO:0043605) regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 2.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.4 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 0.2 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.1 | 0.3 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 | 0.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 | 4.6 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
| 0.1 | 0.3 | GO:0033006 | regulation of myeloid leukocyte mediated immunity(GO:0002886) regulation of mast cell activation involved in immune response(GO:0033006) regulation of leukocyte degranulation(GO:0043300) regulation of mast cell degranulation(GO:0043304) |
| 0.1 | 0.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.1 | 0.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.3 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
| 0.1 | 1.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 1.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 0.4 | GO:0046886 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.1 | 0.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 0.1 | GO:0051030 | snRNA export from nucleus(GO:0006408) snRNA transport(GO:0051030) |
| 0.1 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.5 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.1 | 0.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 | 0.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.1 | 0.8 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 | 3.2 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 5.8 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 1.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 0.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.1 | 2.1 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.1 | 1.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.4 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.1 | 2.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 | 1.1 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) endothelial tube morphogenesis(GO:0061154) |
| 0.1 | 0.1 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
| 0.1 | 0.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 0.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.1 | 1.0 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.1 | 0.1 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 | 1.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
| 0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 0.1 | 0.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 | 1.2 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
| 0.1 | 1.7 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.3 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 | 0.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.1 | 0.2 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 | 1.8 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 0.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.1 | 2.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 4.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.1 | 1.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 | 0.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 | 0.2 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.3 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 0.1 | 7.6 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.1 | 3.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.1 | 0.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 0.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 | 0.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 2.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 0.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.1 | 0.6 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.1 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 1.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 0.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 0.5 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 | 0.2 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 0.1 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.1 | 0.2 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 | 0.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 | 0.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 0.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 0.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.1 | 0.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.1 | 0.9 | GO:1902932 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) positive regulation of alcohol biosynthetic process(GO:1902932) |
| 0.1 | 1.6 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 | 1.4 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.0 | 0.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.0 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 | 0.6 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.1 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
| 0.0 | 0.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.0 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 | 0.2 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
| 0.0 | 0.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.0 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 | 1.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 1.5 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.0 | 2.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.0 | 0.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.0 | 0.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 0.2 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.0 | 0.1 | GO:0043132 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) NAD transport(GO:0043132) |
| 0.0 | 1.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 | 0.0 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.0 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.0 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 | 0.2 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.0 | 0.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.0 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 | 2.1 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.0 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.0 | 0.3 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.0 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 | 0.1 | GO:0070541 | response to platinum ion(GO:0070541) |
| 0.0 | 0.7 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
| 0.0 | 0.1 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 | 0.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 | 0.0 | GO:0034394 | protein localization to cell surface(GO:0034394) |
| 0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.0 | 1.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 3.7 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.0 | 0.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 1.5 | GO:0000725 | recombinational repair(GO:0000725) |
| 0.0 | 4.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.0 | 0.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.0 | 1.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.0 | 0.1 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.0 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.0 | 0.2 | GO:2000726 | negative regulation of cardiac muscle cell differentiation(GO:2000726) |
| 0.0 | 3.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.0 | 0.1 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 0.0 | 0.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.0 | 0.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 | 0.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) positive regulation of opsonization(GO:1903028) |
| 0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.0 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.0 | 4.4 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
| 0.0 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.0 | 0.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 | 0.2 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.0 | 0.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
| 0.0 | 0.1 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.0 | 1.4 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.0 | 0.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.0 | 0.6 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.3 | GO:0050951 | detection of temperature stimulus(GO:0016048) sensory perception of temperature stimulus(GO:0050951) |
| 0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 | 0.1 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.0 | 0.5 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 0.0 | 1.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.0 | 0.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.0 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.0 | 0.2 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.0 | 0.1 | GO:0050777 | negative regulation of immune response(GO:0050777) |
| 0.0 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 | 2.0 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
| 0.0 | 1.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 0.5 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.0 | 0.4 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
| 0.0 | 0.2 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.0 | 0.6 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 | 0.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 | 1.5 | GO:0030097 | hemopoiesis(GO:0030097) |
| 0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 | 0.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 | 0.3 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 | 0.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.0 | 1.3 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.0 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.9 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.0 | 0.1 | GO:0001839 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) substrate-dependent cell migration, cell attachment to substrate(GO:0006931) mesoderm migration involved in gastrulation(GO:0007509) mesodermal cell migration(GO:0008078) axial mesoderm morphogenesis(GO:0048319) |
| 0.0 | 0.9 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.0 | 0.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.0 | 0.4 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 0.0 | 2.2 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
| 0.0 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 | 0.5 | GO:0030728 | ovulation(GO:0030728) |
| 0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.0 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 0.0 | GO:2000779 | regulation of double-strand break repair(GO:2000779) |
| 0.0 | 0.2 | GO:0043545 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 | 0.1 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 | 0.0 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.0 | 0.1 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.0 | 1.4 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.1 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090101) |
| 0.0 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.0 | 0.1 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.0 | 0.1 | GO:0015862 | uridine transport(GO:0015862) |
| 0.0 | 1.9 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.2 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.0 | 0.0 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.0 | 0.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.0 | 0.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 | 0.0 | GO:0030820 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.0 | 0.2 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.0 | 0.1 | GO:0032347 | regulation of aldosterone metabolic process(GO:0032344) negative regulation of aldosterone metabolic process(GO:0032345) regulation of aldosterone biosynthetic process(GO:0032347) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.0 | 0.1 | GO:0019556 | formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 | 0.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.0 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 | 0.2 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.0 | 0.2 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.0 | 0.1 | GO:0016055 | Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) |
| 0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 | 0.4 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.0 | 0.2 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.0 | 0.8 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.0 | 0.2 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.0 | 0.3 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.0 | 0.2 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.0 | 0.1 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
| 0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.0 | 0.5 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
| 0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.0 | 0.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 | 0.0 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.0 | 0.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.0 | 0.4 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.0 | 0.0 | GO:1902361 | pyruvate transport(GO:0006848) mitochondrial pyruvate transport(GO:0006850) pyruvate transmembrane transport(GO:1901475) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.0 | 1.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.1 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
| 0.0 | 0.5 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.0 | 0.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.0 | 0.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.0 | 0.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.0 | 0.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 0.1 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
| 0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.1 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
| 0.0 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.0 | 0.2 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
| 0.0 | 0.1 | GO:0009636 | response to toxic substance(GO:0009636) |
| 0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.0 | 0.0 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.0 | 3.6 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.0 | 5.5 | GO:0007015 | actin filament organization(GO:0007015) |
| 0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.0 | 1.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 | 0.0 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.0 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.0 | 0.0 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.0 | 0.4 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
| 0.0 | 0.0 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.0 | 0.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 0.5 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.0 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
| 0.0 | 0.0 | GO:2000354 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) regulation of ovarian follicle development(GO:2000354) |
| 0.0 | 0.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 | 0.1 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.0 | 0.2 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
| 0.0 | 0.2 | GO:0031293 | Notch receptor processing(GO:0007220) membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.0 | 0.4 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
| 0.0 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) |
| 0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 0.0 | 0.4 | GO:0007565 | female pregnancy(GO:0007565) |
| 0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.1 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.0 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.0 | 0.1 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
| 0.0 | 0.1 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) long-chain fatty acid catabolic process(GO:0042758) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.0 | 0.1 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
| 0.0 | 0.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.0 | 40.0 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 7.2 | 21.5 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 7.0 | 21.0 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 6.6 | 19.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 6.5 | 32.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 6.3 | 50.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 4.3 | 12.9 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 3.9 | 15.5 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 3.6 | 18.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 3.5 | 10.5 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 2.6 | 25.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 2.2 | 8.7 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 2.0 | 8.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 1.9 | 7.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 1.8 | 16.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 1.7 | 8.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 1.7 | 67.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 1.6 | 4.9 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 1.6 | 3.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 1.5 | 4.6 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 1.5 | 2.9 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 1.5 | 4.4 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 1.4 | 4.2 | GO:1990031 | pinceau fiber(GO:1990031) |
| 1.4 | 4.2 | GO:0097447 | dendritic tree(GO:0097447) |
| 1.3 | 12.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 1.3 | 8.0 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.3 | 5.2 | GO:0000811 | GINS complex(GO:0000811) |
| 1.3 | 9.0 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 1.3 | 1.3 | GO:0000805 | X chromosome(GO:0000805) |
| 1.2 | 19.8 | GO:0042555 | MCM complex(GO:0042555) |
| 1.2 | 27.8 | GO:0010369 | chromocenter(GO:0010369) |
| 1.2 | 3.5 | GO:0005715 | late recombination nodule(GO:0005715) |
| 1.1 | 6.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.9 | 4.6 | GO:0035838 | growing cell tip(GO:0035838) |
| 0.9 | 5.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.8 | 10.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.8 | 17.4 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.8 | 58.0 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.7 | 7.8 | GO:0043203 | axon hillock(GO:0043203) |
| 0.7 | 6.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.7 | 1.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.7 | 0.7 | GO:0098588 | bounding membrane of organelle(GO:0098588) |
| 0.7 | 2.6 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.6 | 3.0 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.6 | 10.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.6 | 3.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.6 | 4.0 | GO:0033503 | HULC complex(GO:0033503) |
| 0.6 | 6.7 | GO:0045120 | pronucleus(GO:0045120) |
| 0.6 | 0.6 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.5 | 26.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.5 | 6.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.5 | 22.2 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.5 | 1.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.4 | 17.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.4 | 3.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.4 | 1.7 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.4 | 1.3 | GO:0071065 | dense core granule membrane(GO:0032127) alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.4 | 3.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 41.3 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.4 | 2.5 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 0.4 | 1.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 0.4 | 15.7 | GO:0000776 | kinetochore(GO:0000776) |
| 0.4 | 1.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.4 | 11.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.4 | 1.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.4 | 3.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.4 | 9.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 6.1 | GO:0090543 | Flemming body(GO:0090543) |
| 0.4 | 1.8 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.3 | 5.2 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.3 | 2.7 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 2.7 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.3 | 3.0 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.3 | 1.0 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.3 | 4.1 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.3 | 3.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 3.3 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.3 | 15.8 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.3 | 4.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 0.9 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.3 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.3 | 2.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.3 | 0.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.3 | 1.9 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 2.4 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 2.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.3 | 2.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.3 | 2.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 1.0 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.2 | 2.5 | GO:0034709 | methylosome(GO:0034709) |
| 0.2 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 0.7 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.2 | 1.9 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 2.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.2 | 1.4 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.2 | 27.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.2 | 1.8 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 1.3 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.2 | 1.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.2 | 2.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 4.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.2 | 1.4 | GO:0071546 | pi-body(GO:0071546) |
| 0.2 | 1.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.2 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.2 | 1.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 10.5 | GO:0005657 | replication fork(GO:0005657) |
| 0.2 | 2.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.2 | 1.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 1.7 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.2 | 2.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.2 | 1.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.2 | 0.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.2 | 0.6 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 2.9 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.2 | 1.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.2 | 17.8 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 2.4 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 1.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 10.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 3.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 1.2 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 0.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 0.4 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.1 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 3.5 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 4.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.1 | 2.4 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.1 | 0.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.1 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 2.1 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 0.5 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 1.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.1 | 2.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 1.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 2.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.4 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.1 | 19.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.1 | 0.6 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 3.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 1.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 1.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 1.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 7.5 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 0.3 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.1 | 14.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.1 | 0.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 0.4 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
| 0.1 | 1.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 0.9 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 0.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 1.4 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 1.0 | GO:0097517 | stress fiber(GO:0001725) actin filament bundle(GO:0032432) contractile actin filament bundle(GO:0097517) |
| 0.1 | 0.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 0.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 5.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 1.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 0.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 1.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
| 0.1 | 0.6 | GO:0071010 | prespliceosome(GO:0071010) |
| 0.1 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 0.4 | GO:0032449 | CBM complex(GO:0032449) lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 3.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.7 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 0.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.1 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 0.2 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.1 | 5.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 2.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
| 0.1 | 1.5 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 0.7 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 0.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.1 | 53.1 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.1 | 7.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.1 | 2.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 0.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.1 | 4.3 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 4.7 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 2.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.1 | 3.3 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.1 | 0.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 3.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 0.2 | GO:0031673 | H zone(GO:0031673) |
| 0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 5.5 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.0 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.0 | 1.6 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.0 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
| 0.0 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.0 | 0.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.0 | 0.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.0 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.0 | 0.3 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 1.6 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 1.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.0 | 1.5 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.0 | 4.9 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
| 0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 1.8 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.6 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 1.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.0 | 0.2 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.0 | 0.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.0 | 0.3 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.0 | 0.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.0 | 0.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 9.7 | GO:0005694 | chromosome(GO:0005694) |
| 0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.0 | 1.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 1.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.0 | 0.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.0 | 2.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
| 0.0 | 0.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.0 | 0.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 1.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 0.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 1.3 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 9.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 3.6 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.0 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
| 0.0 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.0 | 41.7 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.8 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.0 | 0.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.0 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.3 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
| 0.0 | 0.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.0 | 0.5 | GO:0043292 | contractile fiber(GO:0043292) |
| 0.0 | 0.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.6 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
| 0.0 | 0.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 3.1 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 0.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.6 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.0 | 21.0 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 6.9 | 48.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 4.8 | 42.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 4.1 | 12.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 3.6 | 18.0 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 3.2 | 15.8 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 2.7 | 13.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 2.5 | 19.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 2.2 | 9.0 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 2.2 | 37.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 2.1 | 6.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 2.1 | 8.3 | GO:0030395 | lactose binding(GO:0030395) |
| 2.0 | 14.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 2.0 | 8.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 1.7 | 8.5 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 1.5 | 4.5 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 1.5 | 7.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.4 | 4.3 | GO:0098809 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 1.4 | 11.3 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 1.4 | 8.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 1.3 | 6.5 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 1.2 | 6.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 1.2 | 4.9 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 1.2 | 3.7 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 1.2 | 21.6 | GO:0035173 | histone kinase activity(GO:0035173) |
| 1.2 | 14.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 1.2 | 4.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 1.1 | 5.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 1.1 | 69.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 1.1 | 4.3 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.1 | 3.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.9 | 6.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.9 | 47.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.9 | 4.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.8 | 4.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.8 | 2.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.8 | 2.3 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.7 | 2.2 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.7 | 2.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.7 | 2.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.7 | 2.1 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.7 | 2.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.7 | 3.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.6 | 1.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.6 | 2.6 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.6 | 2.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.6 | 22.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.6 | 1.2 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.6 | 3.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.6 | 2.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.6 | 4.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.6 | 5.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.6 | 1.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.6 | 7.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.6 | 3.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.6 | 1.7 | GO:0031177 | S-acetyltransferase activity(GO:0016418) phosphopantetheine binding(GO:0031177) |
| 0.6 | 2.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.5 | 3.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.5 | 46.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.5 | 4.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.5 | 3.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.5 | 3.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.5 | 4.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.5 | 4.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.5 | 15.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.5 | 5.0 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.5 | 5.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.5 | 26.9 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.5 | 5.3 | GO:0008430 | selenium binding(GO:0008430) |
| 0.5 | 1.0 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.5 | 2.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.5 | 0.5 | GO:1901474 | thiamine transmembrane transporter activity(GO:0015234) azole transmembrane transporter activity(GO:1901474) |
| 0.5 | 1.9 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
| 0.5 | 1.4 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.4 | 1.3 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.4 | 1.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.4 | 9.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.4 | 2.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.4 | 8.1 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.4 | 4.2 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.4 | 2.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.4 | 18.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.4 | 15.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.4 | 2.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.4 | 3.2 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.4 | 2.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.4 | 53.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.4 | 1.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.4 | 1.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.4 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.4 | 3.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.4 | 1.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.4 | 21.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.4 | 2.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.4 | 6.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.4 | 7.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.3 | 1.0 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.3 | 9.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.3 | 1.0 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.3 | 9.3 | GO:0005521 | lamin binding(GO:0005521) |
| 0.3 | 1.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.3 | 9.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.3 | 1.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.3 | 0.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.3 | 8.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.3 | 12.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.3 | 1.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.3 | 2.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.3 | 0.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.3 | 1.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.3 | 2.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.3 | 1.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.3 | 3.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 2.0 | GO:0070728 | leucine binding(GO:0070728) |
| 0.3 | 1.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.3 | 0.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.3 | 2.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.3 | 1.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.3 | 2.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.3 | 0.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.3 | 1.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.3 | 5.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.3 | 1.0 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.3 | 20.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.3 | 2.0 | GO:0046790 | virion binding(GO:0046790) |
| 0.3 | 3.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 1.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 11.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.2 | 0.7 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.2 | 1.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.2 | 1.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.2 | 1.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 1.2 | GO:0070905 | serine binding(GO:0070905) |
| 0.2 | 17.4 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.2 | 1.6 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.2 | 0.7 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.2 | 2.0 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.2 | 1.9 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.2 | 0.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.2 | 0.8 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.2 | 1.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.2 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.2 | 1.5 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 1.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 0.6 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.2 | 43.9 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.2 | 3.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.2 | 1.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.2 | 0.4 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.2 | 10.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 0.6 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.2 | 12.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.2 | 2.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.2 | 4.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.2 | 0.6 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.2 | 2.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.2 | 5.8 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.2 | 2.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.2 | 4.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.2 | 1.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.2 | 4.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.2 | 1.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 4.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 0.5 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.2 | 2.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.2 | 0.7 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.2 | 1.0 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.2 | 5.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.2 | 1.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.2 | 0.8 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.2 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
| 0.2 | 2.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 0.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.2 | 4.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.2 | 1.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 1.5 | GO:0015288 | porin activity(GO:0015288) |
| 0.2 | 2.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.2 | 6.5 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 1.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 1.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 1.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 3.6 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.9 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.1 | 0.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.1 | 1.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 0.5 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 1.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.1 | 0.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 0.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 7.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 3.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 2.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 2.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 1.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 2.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 0.4 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 2.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.1 | 3.4 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 0.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 0.2 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
| 0.1 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 4.4 | GO:0043531 | ADP binding(GO:0043531) |
| 0.1 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.1 | 0.6 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
| 0.1 | 0.5 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 10.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.1 | 1.7 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
| 0.1 | 0.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.1 | 0.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.1 | 11.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.1 | 1.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.1 | 0.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 2.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.1 | 0.3 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.1 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 0.3 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.1 | 2.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 0.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.1 | 0.6 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
| 0.1 | 1.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.3 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.1 | 1.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 0.8 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
| 0.1 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.6 | GO:0015294 | solute:cation symporter activity(GO:0015294) |
| 0.1 | 2.0 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.1 | 0.5 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
| 0.1 | 0.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.1 | 0.7 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.1 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 1.2 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.4 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.1 | 0.3 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.1 | 1.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.1 | 1.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 0.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 1.3 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 0.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 0.9 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 6.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.1 | 2.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 2.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 1.3 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 5.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.1 | 0.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
| 0.1 | 0.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.1 | 0.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.1 | 0.2 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.1 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.9 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.1 | 2.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 1.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 3.2 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 0.6 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 0.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.1 | 2.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.1 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 5.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 1.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 0.5 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 9.9 | GO:0042393 | histone binding(GO:0042393) |
| 0.1 | 0.1 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.1 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.1 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 4.4 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.1 | 0.3 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.1 | 0.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 0.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 0.2 | GO:0022839 | ion gated channel activity(GO:0022839) |
| 0.1 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 2.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 1.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.6 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.0 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.0 | 0.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.0 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.0 | 0.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.0 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.0 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 1.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.0 | 0.1 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.0 | 0.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.0 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.0 | 7.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 9.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 0.1 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.0 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.0 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.0 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.0 | 1.0 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 0.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.0 | 0.3 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.0 | 1.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 0.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.0 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.0 | 0.6 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 1.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.0 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 0.1 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.0 | 0.1 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.0 | 0.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.0 | 0.1 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.0 | 0.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.0 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.0 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
| 0.0 | 0.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.0 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 5.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 16.8 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.0 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.0 | 0.2 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.0 | 0.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.0 | 2.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 0.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 0.4 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.0 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.0 | 1.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
| 0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.0 | 3.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.0 | 3.1 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.0 | 0.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.3 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.0 | 0.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.0 | 0.1 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.0 | 0.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
| 0.0 | 9.3 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.0 | 0.1 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.0 | 0.1 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) succinate transmembrane transporter activity(GO:0015141) |
| 0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 0.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 0.1 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.0 | 0.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 0.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.0 | 0.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.0 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
| 0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 0.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) ER retention sequence binding(GO:0046923) |
| 0.0 | 0.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.0 | 0.2 | GO:0016887 | ATPase activity(GO:0016887) |
| 0.0 | 0.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 0.0 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
| 0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.0 | 0.2 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
| 0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.0 | 0.1 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.0 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.9 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.0 | 0.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 1.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.0 | 0.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 1.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 174.8 | PID PLK1 PATHWAY | PLK1 signaling events |
| 1.7 | 115.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.8 | 40.8 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.7 | 39.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.5 | 5.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.4 | 24.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.4 | 3.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.4 | 10.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.4 | 8.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.3 | 24.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.3 | 30.9 | PID E2F PATHWAY | E2F transcription factor network |
| 0.3 | 2.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 6.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 6.0 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.2 | 4.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.2 | 10.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.2 | 13.3 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.2 | 15.2 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.2 | 3.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 9.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 5.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.2 | 6.9 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 10.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 3.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 6.1 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 0.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 2.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 3.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 1.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 1.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 1.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 5.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 6.8 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 4.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 0.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 1.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 1.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 2.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 4.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 1.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 2.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 2.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 0.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 1.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 2.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 3.2 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 0.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 2.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 2.4 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 1.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 1.2 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 3.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 1.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.0 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.0 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.0 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.0 | 0.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.6 | 3.6 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 3.3 | 90.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 3.0 | 96.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 2.6 | 47.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 1.8 | 64.9 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 1.4 | 29.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 1.4 | 53.1 | REACTOME KINESINS | Genes involved in Kinesins |
| 1.3 | 134.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 1.1 | 8.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 1.0 | 7.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.9 | 5.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.8 | 15.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.8 | 7.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.8 | 20.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.8 | 15.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.6 | 12.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.6 | 14.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.6 | 6.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.5 | 26.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.5 | 16.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.5 | 4.7 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.4 | 9.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.4 | 30.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.4 | 8.5 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.4 | 5.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.3 | 5.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.3 | 12.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.3 | 1.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.3 | 2.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.3 | 5.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.3 | 12.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.3 | 3.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.3 | 10.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.3 | 19.4 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.3 | 4.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.3 | 16.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 2.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.2 | 6.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 2.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.2 | 7.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 1.8 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.2 | 10.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.2 | 3.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.2 | 4.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.2 | 0.8 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 0.2 | 4.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 3.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 5.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 1.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 1.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 2.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 4.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 2.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 1.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 2.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 3.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 3.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 2.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 4.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 6.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 1.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 1.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 3.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 1.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 2.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 2.9 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.1 | 2.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.1 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 3.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 1.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.1 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 2.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 1.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 2.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 4.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 4.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 1.7 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 0.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 1.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 1.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.1 | 1.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 3.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 4.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 2.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.0 | 1.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.0 | 0.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.0 | 0.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.0 | 2.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.0 | 1.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.0 | 0.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.0 | 5.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.0 | 0.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.0 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.0 | 0.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.0 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 5.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 1.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 0.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 1.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.0 | 0.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.0 | 0.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 1.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.0 | 0.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.0 | 0.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.0 | 0.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.9 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.0 | 0.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 1.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.2 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 1.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |